-
Corn Next Launches CornNext-17: A Groundbreaking Sustainable Solution to Plastic Pollution
IRVINE, Calif., Fri, Jan 10 2025 10:06 PM
IRVINE, Calif., Jan. 10, 2025 /PRNewswire/ -- Corn Next, a leader in sustainable innovation and biodegradable solutions, has officially launched CornNext-17, a game-changing bio-based material designed to combat the global plastic pollution crisis.… -
Chronic Disease Management: Innovations in Therapeutics, Devices, and Global Markets
BOSTON, Fri, Jan 10 2025 5:48 PM
Emerging Technologies Revolutionize Chronic Disease Management: Insights into Bio-Wearables, Digital Therapeutics, and AI-Driven Solutions BOSTON, Jan. 10, 2025 /PRNewswire/ -- According to the latest study from BCC Research, "Chronic Disease… -
Sobi's full year 2024 revenue higher than previous estimate
STOCKHOLM, Fri, Jan 10 2025 5:45 PM
STOCKHOLM, Jan. 10, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue for the full year 2024 was higher than previous estimate. Full-year revenue was approximately SEK 26,000 M, representing… -
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
FLORENCE, Italy and CAMBRIDGE, Mass., Fri, Jan 10 2025 3:45 PM
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, similar to the preclinical stage KAT6 inhibitor (MEN2312) licensed a year ago and which advanced rapidly into… -
Refurbished Medical Equipment Market to Hit USD 24.41 Billion by 2029 with 7.6% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Fri, Jan 10 2025 3:30 PM
DELRAY BEACH, Fla., Jan. 10, 2025 /PRNewswire/ -- The global Refurbished Medical Equipment market is expected to grow to USD 24.41 Billion by 2029, up from USD 16.93 Billion in 2024, at a CAGR of 7.6% over the forecast period. Some driving the… -
Novo Holdings invests in $200M Series A for Windward Bio launch to advance long-acting treatments for asthma and COPD
COPENHAGEN, Denmark, Fri, Jan 10 2025 2:33 PM
High unmet medical need for therapies that can reduce the substantial treatment burden affecting millions of patients globallyCombined in-licensing and financing for a novel long-acting clinical stage monoclonal antibody targeting TSLP ligand as… -
Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis
UPPSALA, Sweden, Fri, Jan 10 2025 1:24 PM
OX640 is a nasal rescue medication with powder-based epinephrine for the treatment of allergic reactions (incl. anaphylaxis) and is based on the proprietary AmorphOX® technology.The clinical study, OX640-002, evaluated both pharmacokinetic and… -
LGC Board appoints Joydeep Goswami as President & Chief Executive
LONDON, Fri, Jan 10 2025 12:00 PM
LONDON, Jan. 10, 2025 /PRNewswire/ -- LGC has announced that Joydeep Goswami is joining its Board of Directors and Executive Leadership Team (ELT) as President and Chief Executive Officer (CEO). Joydeep succeeds Euan O'Sullivan, who decided to step… -
Diamyd Medical confirms key advances toward Accelerated Approval for Diamyd® following FDA Type C Meeting
STOCKHOLM, Fri, Jan 10 2025 11:07 AM
STOCKHOLM, Jan. 10, 2025 /PRNewswire/ -- Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and Drug Administration (FDA) held in December 2024. The meeting focused on… -
NCCN Joins International Meeting to Improve Cancer Care in the Middle East and North Africa Region
RIYADH, Saudi Arabia, Fri, Jan 10 2025 9:03 AM
Two-day symposium in Riyadh, Saudi Arabia brings together leading oncology professionals from across the MENA region to review updated treatment recommendations. RIYADH, Saudi Arabia, Jan. 10, 2025 /PRNewswire/ -- The National Comprehensive Cancer… -
David Schilansky Appointed Chief Financial Officer of Ariceum Therapeutics
BERLIN, Fri, Jan 10 2025 8:30 AM
BERLIN, Jan. 10, 2025 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced the appointment of David… -
TriNetX's Founding CEO Announces Plans to Step Down
CAMBRIDGE, Mass., Thu, Jan 9 2025 9:05 PM
After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX's Board CAMBRIDGE, Mass., Jan. 9, 2025 /PRNewswire/ -- TriNetX, the largest global source of real-world data, today announced that Gadi Lachman, the Company's Founder,… -
FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025
HERZLIYA, Israel and CALGARY, Alberta, Thu, Jan 9 2025 9:01 PM
HERZLIYA, Israel and CALGARY, Alberta, Jan. 9, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce…